STOCK TITAN

Vicarious Surgical to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
conferences earnings
Rhea-AI Summary
Vicarious Surgical Inc. (RBOT) will report financial results for Q4 and full year 2023 on March 4, 2024. The company aims to enhance surgical procedures through robotics technology.
Positive
  • None.
Negative
  • None.

WALTHAM, Mass.--(BUSINESS WIRE)-- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market closes on Monday, March 4, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by dialing +1 833 470 1428 for domestic callers or +1 404 975 4839 for international callers, using access code: 608739. A live and archived webcast of the event will be available at https://investor.vicarioussurgical.com.

About Vicarious Surgical

Founded in 2014, Vicarious Surgical is a next generation surgical robotics company, developing a unique disruptive technology with the multiple goals of substantially increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to virtually transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com.

Investor Contact

Kaitlyn Brosco

Vicarious Surgical

Kbrosco@vicarioussurgical.com

Marissa Bych

Gilmartin Group

Marissa@gilmartinir.com

Media Inquiries

media@vicarioussurgical.com

Source: Vicarious Surgical Inc.

Vicarious Surgical will report financial results for the fourth quarter and full year ended December 31, 2023, on March 4, 2024.

The ticker symbol for Vicarious Surgical is RBOT.

Investors can listen to the conference call by dialing +1 833 470 1428 for domestic callers or +1 404 975 4839 for international callers, using access code: 608739.

Investors can access the live and archived webcast at https://investor.vicarioussurgical.com.
Vicarious Surgical Inc

NYSE:RBOT

RBOT Rankings

RBOT Latest News

RBOT Stock Data

Surgical Appliance and Supplies Manufacturing
Manufacturing
Link

About RBOT

at vicarious surgical we are revolutionizing the field of surgical robotics. we seek to improve the lives of patients, enhance the ability of surgeons, and expand worldwide access to high-quality care through the use of surgical robotics. we have reimagined what is possible by building a human-like surgical robot and combining it with the world’s first virtual-reality surgical camera to allow surgeons to perform minimally-invasive surgery with the ease of an open procedure.